United Therapeutics | UTHR - Operating Expenses


United Therapeutics reported $804.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Amarin USD 51.48M 113K Dec/2025
Ardelyx USD 120.12M 14.46M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
BioCryst Pharmaceuticals USD 146.17M 534.06M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
BioMarin Pharmaceutical USD 676.18M 131.65M Dec/2025
Emergent BioSolutions USD 555.9M 242.7M Jun/2023
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Halozyme Therapeutics USD 211.07M 74.73M Dec/2025
Insmed USD 513.55M 109.86M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Lexicon Pharmaceuticals USD 20.27M 6.1M Dec/2025
Moderna USD 1.54B 259M Dec/2025
Omeros USD 59.16M 20.13M Jun/2024
Pfizer USD 12.91B 79.89B Dec/2025
PTC Therapeutics USD 246.3M 38.78M Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sarepta Therapeutics USD 853.02M 390.78M Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
United Therapeutics USD 804.8M 5.79B Dec/2025
Vertex Pharmaceuticals USD 1.93B 89.1M Dec/2025